8:50

Key issues (common critical gaps) in cancer determinations. Jack Moore

9:45

Break

10:00

What types of toxicogenomics experiments have been attempted to address critical gaps in risk assessment?

Cheryl Walker and Ken Ramos

10:45

Case Study Discussion: Identify specific situations in risk assessment where toxicogenomics could be very useful and where it would be less useful.

 

Overview of method for case studies discussion.

Linda Greer

 

Case Study Discussion I:

• Presentation of 1,3-Butadiene Risk Assessment. Ken Ramos

• Discussion of 1,3-Butadiene Risk Assessment questions that might be addressed with toxicogenomics techniques. Ken Ramos

1:30

Case Study Discussion II:

• Presentation of Arsenic Risk Assessment. David Eaton

• Discussion of Arsenic Risk Assessment questions that might be addressed with toxicogenomics techniques. Cheryl Walker

3:15

Break

3:35

Discussion and summary of issues presented in each of the two chemicals, with an aim of generalizing to list of opportunities for the field of toxicogenomics. Linda Greer

5:15

Adjourn



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement